Package 0054-0334-25

Brand: cevimeline hydrochloride

Generic: cevimeline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0054-0334-25
Digits Only 0054033425
Product NDC 0054-0334
Product ID 0054-0334_3cca3720-dca8-40cf-8de7-8f3444125ece
Description

100 CAPSULE in 1 BOTTLE (0054-0334-25)

Marketing

Marketing Status
Marketed Since 2013-07-08
Brand cevimeline hydrochloride
Generic cevimeline hydrochloride
Sample Package No

Linked Drug Pages (1)

Cevimeline Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3cca3720-dca8-40cf-8de7-8f3444125ece", "openfda": {"upc": ["0300540334253"], "unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["1167360c-7e0f-4619-9d1a-ad4ee56cab71"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0054-0334-25)", "package_ndc": "0054-0334-25", "marketing_start_date": "20130708"}], "brand_name": "Cevimeline Hydrochloride", "product_id": "0054-0334_3cca3720-dca8-40cf-8de7-8f3444125ece", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "0054-0334", "generic_name": "Cevimeline Hydrochloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cevimeline Hydrochloride", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA091591", "marketing_category": "ANDA", "marketing_start_date": "20130708", "listing_expiration_date": "20261231"}